CN113750194A - Formula for treating new coronavirus - Google Patents

Formula for treating new coronavirus Download PDF

Info

Publication number
CN113750194A
CN113750194A CN202110133425.XA CN202110133425A CN113750194A CN 113750194 A CN113750194 A CN 113750194A CN 202110133425 A CN202110133425 A CN 202110133425A CN 113750194 A CN113750194 A CN 113750194A
Authority
CN
China
Prior art keywords
parts
root
formula
raw materials
following raw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110133425.XA
Other languages
Chinese (zh)
Inventor
肖春林
肖懿
董杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Chunlin Pharmaceutical Machinery Co ltd
Original Assignee
Hubei Chunlin Pharmaceutical Machinery Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei Chunlin Pharmaceutical Machinery Co ltd filed Critical Hubei Chunlin Pharmaceutical Machinery Co ltd
Priority to CN202110133425.XA priority Critical patent/CN113750194A/en
Publication of CN113750194A publication Critical patent/CN113750194A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/342—Adenophora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/78—Saururaceae (Lizard's-tail family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964—Anemarrhena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966—Fritillaria, e.g. checker lily or mission bells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/904—Stemonaceae (Stemona family), e.g. croomia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a formula for treating new coronavirus, which is prepared by the following steps of: the prescription for treating mild diseases or suspected diseases comprises the following raw materials in parts by weight: 8-11 parts of pinellia ternate, 8-11 parts of radix stemonae, 8-11 parts of cortex mori radicis, 8-11 parts of blackberry lily, 8-11 parts of subprostrate sophora, 8-11 parts of platycodon grandiflorum, 8-11 parts of radix ophiopogonis, 8-11 parts of honeysuckle, 8-11 parts of almond, 8-11 parts of semen trichosanthis, 8-11 parts of rhizoma atractylodis, 8-11 parts of cyrtomium fortunei, 6-9 parts of pericarpium citri reticulatae, 6-9 parts of liquorice, 6-9 parts of schisandra chinensis, 10-13 parts of fructus forsythiae and 12-16 parts of poria cocos; the invention has the advantages that: the formula adopts common herbal medicines, and the traditional Chinese medicine is decocted by adding water according to the required dosage and then taken orally, so that the traditional Chinese medicine is simple and convenient, and has quick response and good curative effect.

Description

Formula for treating new coronavirus
Technical Field
The invention relates to the field of medicines, in particular to the field of traditional Chinese medicines for treating new coronavirus.
Background
Aiming at the existing patients infected by the new coronavirus, the treatment is a great problem, and the death rate is high, so that more effective medicines are urgently needed to treat the patients infected by the new coronavirus so as to save the lives of the patients infected by the new coronavirus.
Disclosure of Invention
The invention aims to provide a formula for treating the new coronavirus, which has the advantages of high treatment speed, good treatment effect and small side effect.
The technical solution adopted by the invention is as follows:
the prescription for treating the new coronavirus is characterized in that the following prescriptions are respectively adopted according to the disease degree of an infected patient:
a. the prescription for treating mild diseases or suspected diseases comprises the following raw materials in parts by weight: 8-11 parts of pinellia ternate, 8-11 parts of radix stemonae, 8-11 parts of cortex mori radicis, 8-11 parts of blackberry lily, 8-11 parts of subprostrate sophora, 8-11 parts of platycodon grandiflorum, 8-11 parts of radix ophiopogonis, 8-11 parts of honeysuckle, 8-11 parts of almond, 8-11 parts of semen trichosanthis, 8-11 parts of rhizoma atractylodis, 8-11 parts of cyrtomium fortunei, 6-9 parts of pericarpium citri reticulatae, 6-9 parts of liquorice, 6-9 parts of schisandra chinensis, 10-13 parts of fructus forsythiae and 12-16 parts of poria cocos;
b. the formula for treating severe cough with coarse qi and hoarseness comprises the following raw materials in parts by weight: 6-9 parts of mulberry leaf, 6-9 parts of whiteflower hogfennel root, 6-9 parts of platycodon root, 6-9 parts of cyrtomium rhizome, 8-11 parts of chrysanthemum, 8-11 parts of weeping forsythia capsule, 8-11 parts of almond, 8-11 parts of reed rhizome, 8-11 parts of mongolian snakegourd root, 8-11 parts of adenophora root, 8-11 parts of dwarf lilyturf tuber, 8-11 parts of baical skullcap root, 8-11 parts of anemarrhena asphodeloides bunge and 13-16 parts of gypsum;
c. the formula of the critical illness state comprises the following raw materials in parts by weight: 8-11 parts of fritillary bulb, 8-11 parts of snakegourd fruit, 8-11 parts of white mulberry root-bark, 8-11 parts of scutellaria baicalensis, 8-11 parts of coix seed, 8-11 parts of houttuynia cordata, 8-11 parts of trichosanthes root, 8-11 parts of radix ophiopogonis, 8-11 parts of semen lepidii, 8-11 parts of rhizoma pinellinae praeparata, 10-13 parts of gardenia jasminoides, 13-16 parts of gypsum and 10-13 parts of cyrtomium rhizome.
The following optimal formulas are respectively adopted according to the disease degree of an infected patient:
a. the prescription for treating mild diseases or suspected diseases comprises the following raw materials in parts by weight: 10 g of pinellia ternate, 10 g of radix stemonae, 10 g of cortex mori, 10 g of blackberry lily, 10 g of subprostrate sophora, 10 g of platycodon grandiflorum, 10 g of radix ophiopogonis, 10 g of honeysuckle, 10 g of almond, 10 g of semen trichosanthis, 10 g of rhizoma atractylodis, 10 g of cyrtomium rhizome, 8 g of dried orange peel, 8 g of liquorice, 8 g of schisandra chinensis, 12 g of fructus forsythiae and 15 g of poria cocos;
b. the formula for treating severe cough with coarse qi and hoarseness comprises the following raw materials in parts by weight: 8 g of mulberry leaf, 8 g of peucedanum root, 8 g of balloonflower root, 8 g of cyrtomium rhizome, 10 g of chrysanthemum, 10 g of forsythia, 10 g of almond, 10 g of reed rhizome, 10 g of trichosanthes root, 10 g of adenophora root, 10 g of dwarf lilyturf tuber, 10 g of scutellaria baicalensis, 10 g of rhizoma anemarrhenae and 15 g of gypsum;
c. the formula of the critical illness state comprises the following raw materials in parts by weight: 10 g of fritillary bulb, 10 g of snakegourd fruit, 10 g of white mulberry root-bark, 10 g of baical skullcap root, 10 g of coix seed, 10 g of heartleaf houttuynia herb, 10 g of Mongolian snakegourd root, 10 g of dwarf lilyturf tuber, 10 g of pepperweed seed, 10 g of rhizoma pinellinae praeparata, 12 g of gardenia jasminoides, 15 g of gypsum and 12 g of cyrtomium rhizome.
The formulation of the initial or suspected illness state is decocted for 8-12 minutes by medium fire after 1000-1500 parts of water is added; the formula for treating severe cough with coarse qi and hoarseness comprises 1000-1500 parts of water and decocting with medium fire for 12-15 minutes; the formulation of the critical illness state is decocted for 12-15 minutes by medium fire after 1000-1500 parts of water is added.
The invention adopts the technical proposal to achieve the following beneficial effects:
according to the pathology, for patients with mild symptoms or suspected diseases, pinellia ternate, radix stemonae, vietnamese sophora root, platycodon grandiflorum and other traditional Chinese medicines for relieving cough and reducing sputum are adopted in the formula, throat pain, dry mouth and tongue can be solved, the upper respiratory tract is benefited, radix ophiopogonis is added for replenishing water, and honeysuckle, almond, rhizoma atractylodis, dried orange peel, liquorice, fructus forsythiae and other traditional Chinese medicines are added, so that the heat-clearing and detoxifying effects are achieved, the formula has a restraining effect on viruses, the effect is quickly achieved, the patients with fever generally get a great improvement in 2-3 days, and the disease is effectively recovered within about one month; for patients with severe cough, coarse qi and hoarseness, the traditional Chinese medicine composition is mainly used for treating lung yin deficiency and has the effect of nourishing yin; the traditional Chinese medicine composition is mainly used for clearing heat viruses for patients with critical disease, can achieve the effects of clearing lung heat, relieving sore throat, reducing phlegm, relieving cough and resisting viruses, adopts common herbal medicines in the formula, is decocted with water according to the required dosage and then taken orally, and is simple and convenient, quick in effect and good in curative effect.
The specific implementation mode is as follows:
the first embodiment is as follows: the prescription for treating the new coronavirus is characterized in that the following prescriptions are respectively adopted according to the disease degree of an infected patient:
a. the prescription for treating mild symptoms or suspected diseases comprises the following raw materials in parts by weight: 8 g of pinellia ternate, 8 g of radix stemonae, 8 g of cortex mori radicis, 8 g of blackberry lily, 8 g of subprostrate sophora, 8 g of platycodon grandiflorum, 8 g of radix ophiopogonis, 8 g of honeysuckle, 8 g of almond, 8 g of snakegourd seed, 8 g of rhizoma atractylodis, 8 g of cyrtomium rhizome, 6 g of dried orange peel, 6 g of liquorice, 6 g of schisandra chinensis, 10 g of fructus forsythiae and 12 g of poria cocos, 1000 g to 1500 g of water is added, then the mixture is decocted for 8 to 12 minutes by medium fire, and the amount of drinking the mixture is 100 g to 150 g every two days;
b. the formula for treating severe cough with coarse qi and hoarseness comprises the following raw materials in parts by weight: 6 g of mulberry leaf, 6 g of peucedanum root, 6 g of platycodon root, 6 g of cyrtomium rhizome, 8 g of chrysanthemum, 8 g of forsythia, 8 g of almond, 8 g of reed rhizome, 8 g of trichosanthes root, 8 g of adenophora root, 8 g of dwarf lilyturf tuber, 8 g of scutellaria baicalensis, 8 g of rhizoma anemarrhenae and 13 g of gypsum, adding 1000 g to 1500 g of water, decocting for 12 to 15 minutes by using medium fire, and drinking the tea in two days, wherein the drinking amount is 100 g to 150 g each time;
c. the formula of the critical illness state comprises the following raw materials in parts by weight: 8 g of fritillary bulb, 8 g of snakegourd fruit, 8 g of white mulberry root-bark, 8 g of baical skullcap root, 8 g of coix seed, 8 g of heartleaf houttuynia herb, 8 g of Mongolian snakegourd root, 8 g of dwarf lilyturf tuber, 8 g of pepperweed seed, 8 g of rhizoma pinellinae praeparata, 10 g of gardenia jasminoides ellis, 13 g of gypsum and 10 g of cyrtomium rhizome, 1000 g-1500 g of water is added, the mixture is decocted for 12-15 minutes by medium fire, the mixture is drunk in two days, and the amount of each drinking is 100 g-150 g.
The second embodiment: the prescription for treating the new coronavirus is characterized in that the following prescriptions are respectively adopted according to the disease degree of an infected patient:
a. the prescription for treating mild symptoms or suspected diseases comprises the following raw materials in parts by weight: 11 g of pinellia ternate, 11 g of radix stemonae, 11 g of cortex mori radicis, 11 g of blackberrylily rhizome, 11 g of subprostrate sophora, 11 g of platycodon grandiflorum, 11 g of radix ophiopogonis, 11 g of honeysuckle, 11 g of almond, 11 g of semen trichosanthis, 11 g of rhizoma atractylodis, 11 g of cyrtomium rhizome, 9 g of dried orange peel, 9 g of liquorice, 9 g of schisandra chinensis, 13 g of fructus forsythiae and 16 g of poria cocos, 1000 g-1500 g of water is added, then the mixture is decocted for 8-12 minutes by medium fire, and the mixture is drunk in two days, wherein the drinking amount of each time is 100 g-150 g;
b. the formula for treating severe cough with coarse qi and hoarseness comprises the following raw materials in parts by weight: 9 g of mulberry leaf, 9 g of peucedanum root, 9 g of platycodon root, 9 g of cyrtomium rhizome, 11 g of chrysanthemum, 11 g of weeping forsythia, 11 g of almond, 11 g of reed rhizome, 11 g of mongolian snakegourd root, 11 g of adenophora root, 11 g of dwarf lilyturf tuber, 11 g of baical skullcap root, 11 g of common anemarrhena rhizome and 16 g of gypsum, adding 1000 g to 1500 g of water, decocting for 12 to 15 minutes by using medium fire, and drinking the mixture in two days, wherein the drinking amount is 100 g to 150 g each time;
c. the formula of the critical illness state comprises the following raw materials in parts by weight: 11 g of fritillary bulb, 11 g of snakegourd fruit, 11 g of white mulberry root-bark, 11 g of baical skullcap root, 11 g of coix seed, 11 g of heartleaf houttuynia herb, 11 g of Mongolian snakegourd root, 11 g of dwarf lilyturf tuber, 11 g of pepperweed seed, 11 g of rhizoma pinellinae praeparata, 13 g of gardenia jasminoides ellis, 16 g of gypsum and 13 g of cyrtomium rhizome, 1000 g-1500 g of water is added, the mixture is decocted for 12-15 minutes by medium fire, the mixture is drunk in two days, and the amount of each drinking is 100 g-150 g.
The third embodiment is as follows: the prescription for treating the new coronavirus is characterized in that the following prescriptions are respectively adopted according to the disease degree of an infected patient:
a. the prescription for treating mild symptoms or suspected diseases comprises the following raw materials in parts by weight: 10 g of pinellia ternate, 10 g of radix stemonae, 10 g of cortex mori, 10 g of blackberry lily, 10 g of subprostrate sophora, 10 g of platycodon grandiflorum, 10 g of radix ophiopogonis, 10 g of honeysuckle, 10 g of almond, 10 g of snakegourd seed, 10 g of rhizoma atractylodis, 10 g of cyrtomium rhizome, 8 g of dried orange peel, 8 g of liquorice, 8 g of schisandra chinensis, 12 g of fructus forsythiae and 15 g of poria cocos, 1000 g-1500 g of water is added, then the mixture is decocted for 8-12 minutes by medium fire, and the amount of the mixture is 100 g-150 g after the mixture is drunk every two days;
b. the formula for treating severe cough with coarse qi and hoarseness comprises the following raw materials in parts by weight: 8 g of mulberry leaf, 8 g of peucedanum root, 8 g of platycodon root, 8 g of cyrtomium rhizome, 10 g of chrysanthemum, 10 g of weeping forsythia, 10 g of almond, 10 g of reed rhizome, 10 g of mongolian snakegourd root, 10 g of adenophora root, 10 g of dwarf lilyturf tuber, 10 g of baical skullcap root, 10 g of common anemarrhena rhizome and 15 g of gypsum, adding 1000 g to 1500 g of water, decocting for 12 to 15 minutes by using medium fire, and drinking the mixture in two days, wherein the drinking amount is 100 g to 150 g each time;
c. the formula of the critical illness state comprises the following raw materials in parts by weight: 10 g of fritillary bulb, 10 g of snakegourd fruit, 10 g of white mulberry root-bark, 10 g of baical skullcap root, 10 g of coix seed, 10 g of heartleaf houttuynia herb, 10 g of Mongolian snakegourd root, 10 g of dwarf lilyturf tuber, 10 g of pepperweed seed, 10 g of rhizoma pinellinae praeparata, 12 g of gardenia jasminoides ellis, 15 g of gypsum and 12 g of cyrtomium rhizome, 1000 g-1500 g of water is added, the mixture is decocted for 12-15 minutes by medium fire, the mixture is drunk in two days, and the amount of each drinking is 100 g-150 g.

Claims (3)

1. A formula for treating new coronavirus is characterized in that: aiming at the disease degree of an infected patient, the following formulas are respectively adopted:
a. the prescription for treating mild diseases or suspected diseases comprises the following raw materials in parts by weight: 8-11 parts of pinellia ternate, 8-11 parts of radix stemonae, 8-11 parts of cortex mori radicis, 8-11 parts of blackberry lily, 8-11 parts of subprostrate sophora, 8-11 parts of platycodon grandiflorum, 8-11 parts of radix ophiopogonis, 8-11 parts of honeysuckle, 8-11 parts of almond, 8-11 parts of semen trichosanthis, 8-11 parts of rhizoma atractylodis, 8-11 parts of cyrtomium fortunei, 6-9 parts of pericarpium citri reticulatae, 6-9 parts of liquorice, 6-9 parts of schisandra chinensis, 10-13 parts of fructus forsythiae and 12-16 parts of poria cocos;
b. the formula for treating severe cough with coarse qi and hoarseness comprises the following raw materials in parts by weight: 6-9 parts of mulberry leaf, 6-9 parts of whiteflower hogfennel root, 6-9 parts of platycodon root, 6-9 parts of cyrtomium rhizome, 8-11 parts of chrysanthemum, 8-11 parts of weeping forsythia capsule, 8-11 parts of almond, 8-11 parts of reed rhizome, 8-11 parts of mongolian snakegourd root, 8-11 parts of adenophora root, 8-11 parts of dwarf lilyturf tuber, 8-11 parts of baical skullcap root, 8-11 parts of anemarrhena asphodeloides bunge and 13-16 parts of gypsum;
c. the formula of the critical illness state comprises the following raw materials in parts by weight: 8-11 parts of fritillary bulb, 8-11 parts of snakegourd fruit, 8-11 parts of white mulberry root-bark, 8-11 parts of scutellaria baicalensis, 8-11 parts of coix seed, 8-11 parts of houttuynia cordata, 8-11 parts of trichosanthes root, 8-11 parts of radix ophiopogonis, 8-11 parts of semen lepidii, 8-11 parts of rhizoma pinellinae praeparata, 10-13 parts of gardenia jasminoides, 13-16 parts of gypsum and 10-13 parts of cyrtomium rhizome.
2. The formulation of claim 1, wherein the formulation is selected from the group consisting of: the following optimal formulas are respectively adopted according to the disease degree of an infected patient:
a. the prescription for treating mild diseases or suspected diseases comprises the following raw materials in parts by weight: 10 g of pinellia ternate, 10 g of radix stemonae, 10 g of cortex mori, 10 g of blackberry lily, 10 g of subprostrate sophora, 10 g of platycodon grandiflorum, 10 g of radix ophiopogonis, 10 g of honeysuckle, 10 g of almond, 10 g of semen trichosanthis, 10 g of rhizoma atractylodis, 10 g of cyrtomium rhizome, 8 g of dried orange peel, 8 g of liquorice, 8 g of schisandra chinensis, 12 g of fructus forsythiae and 15 g of poria cocos;
b. the formula for treating severe cough with coarse qi and hoarseness comprises the following raw materials in parts by weight: 8 g of mulberry leaf, 8 g of peucedanum root, 8 g of balloonflower root, 8 g of cyrtomium rhizome, 10 g of chrysanthemum, 10 g of forsythia, 10 g of almond, 10 g of reed rhizome, 10 g of trichosanthes root, 10 g of adenophora root, 10 g of dwarf lilyturf tuber, 10 g of scutellaria baicalensis, 10 g of rhizoma anemarrhenae and 15 g of gypsum;
c. the formula of the critical illness state comprises the following raw materials in parts by weight: 10 g of fritillary bulb, 10 g of snakegourd fruit, 10 g of white mulberry root-bark, 10 g of baical skullcap root, 10 g of coix seed, 10 g of heartleaf houttuynia herb, 10 g of Mongolian snakegourd root, 10 g of dwarf lilyturf tuber, 10 g of pepperweed seed, 10 g of rhizoma pinellinae praeparata, 12 g of gardenia jasminoides, 15 g of gypsum and 12 g of cyrtomium rhizome.
3. The formulation according to claim 1 or 2, characterized in that: the formulation of the initial or suspected illness state is decocted for 8-12 minutes by medium fire after 1000-1500 parts of water is added; the formula for treating severe cough with coarse qi and hoarseness comprises 1000-1500 parts of water and decocting with medium fire for 12-15 minutes; the formulation of the critical illness state is decocted for 12-15 minutes by medium fire after 1000-1500 parts of water is added.
CN202110133425.XA 2021-02-01 2021-02-01 Formula for treating new coronavirus Pending CN113750194A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110133425.XA CN113750194A (en) 2021-02-01 2021-02-01 Formula for treating new coronavirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110133425.XA CN113750194A (en) 2021-02-01 2021-02-01 Formula for treating new coronavirus

Publications (1)

Publication Number Publication Date
CN113750194A true CN113750194A (en) 2021-12-07

Family

ID=78786566

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110133425.XA Pending CN113750194A (en) 2021-02-01 2021-02-01 Formula for treating new coronavirus

Country Status (1)

Country Link
CN (1) CN113750194A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115814033A (en) * 2022-06-27 2023-03-21 天圣制药集团股份有限公司 Traditional Chinese medicine composition for preventing, relieving or treating new coronary pneumonia and pharmaceutical application thereof
CN116159115A (en) * 2023-01-13 2023-05-26 崔书克 Preparation method of novel coronavirus prevention and treatment traditional Chinese medicine composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1440759A (en) * 2002-02-27 2003-09-10 王宁 Composite medicine for treating respirtory system diseases and its prepn process
CN103211939A (en) * 2013-04-15 2013-07-24 陈雪莉 Traditional Chinese medicine granule for strengthening spleen and tonifying lung
CN111569035A (en) * 2020-05-06 2020-08-25 石家庄市第五医院 Traditional Chinese medicine composition and application thereof in preparation of medicine for treating new coronary pneumonia, especially asymptomatic infected patients

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1440759A (en) * 2002-02-27 2003-09-10 王宁 Composite medicine for treating respirtory system diseases and its prepn process
CN103211939A (en) * 2013-04-15 2013-07-24 陈雪莉 Traditional Chinese medicine granule for strengthening spleen and tonifying lung
CN111569035A (en) * 2020-05-06 2020-08-25 石家庄市第五医院 Traditional Chinese medicine composition and application thereof in preparation of medicine for treating new coronary pneumonia, especially asymptomatic infected patients

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
杨林,等: "利咽止咳方治疗喉源性咳嗽60例", 《陕西中医》 *
腾讯网: "武汉协和医院关于"新冠"中医防治方案（第二版）", 《HTTPS://XW.QQ.COM/AMPHTML/20200213A0U7EF00》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115814033A (en) * 2022-06-27 2023-03-21 天圣制药集团股份有限公司 Traditional Chinese medicine composition for preventing, relieving or treating new coronary pneumonia and pharmaceutical application thereof
CN115814033B (en) * 2022-06-27 2023-09-12 天圣制药集团股份有限公司 Chinese medicinal composition for inhibiting novel coronavirus and pharmaceutical use thereof
CN116159115A (en) * 2023-01-13 2023-05-26 崔书克 Preparation method of novel coronavirus prevention and treatment traditional Chinese medicine composition

Similar Documents

Publication Publication Date Title
Wang et al. Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine
CN111150792A (en) Chinese medicinal composition with effect of resisting novel coronavirus SARS-Cov-2, and preparation method and application thereof
CN101940658A (en) Chinese medicinal composition for treating toothache and preparation method thereof
CN113750194A (en) Formula for treating new coronavirus
CN104189563A (en) Traditional Chinese medicine for treating oral ulcer and preparation method thereof
CN103638503A (en) Traditional Chinese medicine granule for preventing and treating influenza and preparation method of traditional Chinese medicine granule
CN111202827A (en) Chinese medicine for preventing influenza, SARS, bird flu and new coronary pneumonia
CN104383496A (en) Drug for treating acute or chronic gastroenteritis
CN102671096A (en) Traditional Chinese medicine for treating ulcer colonitis and preparation method thereof
CN104922442A (en) Traditional Chinese medicine for treating fever
CN104383461A (en) Chinese medicinal composition for treating insomnia due to blood stasis
CN100569263C (en) A kind of pharmaceutical composition for the treatment of stomachache and preparation method thereof
CN102526306A (en) Chinese medicinal composition for treating ulcerative colitis
CN103285221A (en) Traditional Chinese medicine for clearing away heat and toxic materials
CN100391514C (en) Chinese traditional medicine preparation for curing laryngopharyngitis
CN104189784A (en) Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation
CN1125111A (en) Chinese proprietary medicine for curing stomach trouble, duodenal ulcer and chronic gastritis
CN102327526B (en) Traditional Chinese medicine composition for lowering blood sugar
CN104083664A (en) Traditional Chinese medicinal composition for treating recurrent oral ulcer
CN105797092B (en) Yiyuan anti-cold mixture
CN105055657A (en) Spraying agent for improving pain caused by wisdom teeth and preparation method thereof
CN104825752A (en) Traditional Chinese medicine composition for treating chronic bronchitis
CN104815198A (en) Traditional Chinese medicinal decoction for treating diabetes
CN104873802A (en) Traditional Chinese medicine composition for treating nephropyelitis
CN102698177A (en) Traditional Chinese medicine composition for treating colitis and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20211207